A novel platform to enable inhaled naked RNAi medicine for lung cancer

Small interfering RNA (siRNA)-based therapeutics have been used in humans and offer distinct advantages over traditional therapies. However, previous investigations have shown that there are several technical obstacles that need to be overcome before routine clinical applications are used. Currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Yu, Takeshita, Fumitaka, Mizutani, Takayuki, Ohgi, Tadaaki, Kuwano, Kazuyoshi, Ochiya, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839038/
https://www.ncbi.nlm.nih.gov/pubmed/24270189
http://dx.doi.org/10.1038/srep03325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839038/
https://www.ncbi.nlm.nih.gov/pubmed/24270189
http://dx.doi.org/10.1038/srep03325

Ejemplares similares